Dr. Fudim is supported by the American Heart Association, National Heart, Lung, and Blood Institute, Mario Family Award, Duke Chair’s Award, Bayer, and Translating Duke Health Award; and receives consulting fees from AstraZeneca, AxonTherapies, CVRx, Daxor, Edwards LifeSciences, Galvani, NXT Biomedical, and Respicardia. Dr. Tedford has consulting relationships with Medtronic, Aria CV Inc., Acceleron, Arena Pharmaceuticals, Abbott, Medtronic, Itamar, Gradient, Eidos Therapeutics, and United Therapeutics; is on a steering committee for Medtronic, Acceleron, and Abbott; on a research advisory board for Abiomed; and does hemodynamic core laboratory work for Actelion and Merck. Dr. Atkins has reported that she has no relationships relevant to the contents of this paper to disclose.